Jupiter Neurosciences, Inc. Jupiter Neurosciences, Inc.

Jupiter Neurosciences, Inc.

JUNS

Rank in Stocks #32856
Jupiter Neurosciences, Inc. is a pharmaceutical company engaged in... Jupiter Neurosciences, Inc. is a pharmaceutical company engaged in clinical-stage research and development. Its primary focus is on advancing a resveratrol-based platform product, with the main objective of addressing neuro-inflammation. The company's pipeline includes several drug candidates: JNS101 is undergoing Phase II trials for Friedreich's Ataxia, a rare neurological disorder that damages the nervous system and causes mobility issues. Also in Phase II, JNS102 is being developed for mucopolysaccharidosis Type I, JNS107 for MELAS Syndrome, and JNS108 for mild cognitive impairment and early Alzheimer's disease. Furthermore, the company is progressing JNS109 for amyotrophic lateral sclerosis, JNS110 for traumatic brain injury and concussion, and JNS120 as a treatment for COVID-19. Founded in 2016, the company, formerly known as Jupiter Orphan Therapeutics, Inc., adopted its current name in August 2021 and is headquartered in Jupiter, Florida.
Share Price
$1.86
Last synced: 2026-11-12
Market Cap
$1.04M
Change (1 day)
-13.08%
Change (1 year)
48.80%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Trade Jupiter Neurosciences, Inc. (JUNS)

Category

Healthcare
Operating Margin for Jupiter Neurosciences, Inc. (JUNS)
Operating Margin as of November 2026 TTM: -15,166.68%
According to Jupiter Neurosciences, Inc.'s latest financial reports, its current operating margin (TTM) is -15,166.68%. At the end of 2025 the company had an operating margin of -40,873.19%.
Operating Margin history for Jupiter Neurosciences, Inc. from 2019 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) -15,166.68% -62.89%
2025 -40,873.19% 0.00%
2024 0.00% 0.00%
2023 0.00% -100.00%
2022 -1,471.38% 140.28%
2021 -612.36% 272.46%
2020 -164.41% 0.00%
2019 0.00% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
-195.39% -99.99%
US
33.87% -100.00%
US
-116.04% -99.99%
US
25.57% -100.00%
AU
31.23% -100.00%
BE
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.

Questions about Jupiter Neurosciences, Inc.'s operating margin

What is Jupiter Neurosciences, Inc.'s operating margin?

Jupiter Neurosciences, Inc.'s operating margin is -15,166.68%, as of Nov 2026.

What was Jupiter Neurosciences, Inc.'s operating margin in 2025?

In 2025, Jupiter Neurosciences, Inc.'s operating margin was -40,873.19%, compared with 0.00% in 2024.

How has Jupiter Neurosciences, Inc.'s operating margin changed since 2020?

From 2020 to 2025, Jupiter Neurosciences, Inc.'s operating margin was highest in 2024 (0.00%) and lowest in 2025 (-40,873.19%).

How does Jupiter Neurosciences, Inc.'s operating margin compare with similar companies?

Jupiter Neurosciences, Inc.'s operating margin (-15,166.68%) is lower than that of all 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 33.87%.